ロード中...
Bevacizumab Enhances the Therapeutic Efficacy of Irinotecan against Human Head and Neck Squamous Cell Carcinoma Xenografts
Combining antiangiogenic agents with traditional cytotoxic chemotherapy offers the potential to target both vascular and cellular components of a growing tumor mass. Here, we examined the antitumor activity of the vascular endothelial growth factor antibody, Bevacizumab (Avastin®) in combination wit...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3109241/ https://ncbi.nlm.nih.gov/pubmed/21530364 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.oraloncology.2011.04.001 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|